Suresh Durgam Selected Research

Psychomotor Agitation (Akathisia)

11/2018	Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
1/2018	Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
11/2017	Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies.
1/2017	Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
1/2017	Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies.
10/2016	Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
3/2016	An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
3/2016	Cariprazine in the treatment of schizophrenia: a proof-of-concept trial.
3/2016	Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
12/2015	Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh Durgam Research Topics

Disease

21	Schizophrenia (Dementia Praecox) 01/2021 - 02/2014
15	Psychomotor Agitation (Akathisia) 11/2018 - 02/2014
14	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 06/2015
12	Mania (Manias) 01/2020 - 02/2014
8	Nausea 12/2021 - 02/2014
7	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2018 - 02/2014
6	Headache (Headaches) 11/2018 - 02/2015
6	Anxiety Disorders (Anxiety Disorder) 01/2017 - 06/2015
5	Basal Ganglia Diseases (Basal Ganglia Disease) 03/2016 - 02/2014
4	Sleepiness 12/2021 - 10/2016
4	Constipation 11/2018 - 02/2014
4	Tremor (Tremors) 03/2016 - 03/2015
3	Diarrhea 11/2018 - 06/2015
3	Fatigue 11/2018 - 06/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2017
3	Weight Gain 01/2018 - 03/2016
3	Vomiting 01/2017 - 03/2015
3	Dizziness (Lightheadedness) 12/2016 - 02/2014
2	Erectile Dysfunction 12/2016 - 01/2016
2	Ejaculatory Dysfunction 12/2016 - 01/2016
2	Dyspepsia (Indigestion) 03/2015 - 02/2015
1	Nasopharyngitis 11/2018
1	Arthralgia (Joint Pain) 11/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 10/2016
1	Back Pain (Backache) 03/2016
1	Parkinsonian Disorders (Parkinsonism) 02/2015

Drug/Important Bio-Agent (IBA)

28	cariprazineIBA 01/2020 - 02/2014
11	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 02/2015
9	Vilazodone HydrochlorideIBA 11/2018 - 06/2015
8	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2016
4	5-HT1A Serotonin ReceptorIBA 01/2019 - 06/2015
4	asenapine FDA Link 01/2018 - 10/2016
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 06/2015
2	lumateperoneIBA 12/2021 - 01/2021
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 01/2017
2	Aripiprazole (Abilify)FDA Link 01/2019 - 12/2015
2	LevomilnacipranIBA 01/2019 - 12/2017
2	Antidepressive Agents (Antidepressants)IBA 11/2018 - 03/2016
2	ProlactinIBA 01/2018 - 11/2017
1	Type A Botulinum Toxins (Botox)FDA Link 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Pharmaceutical PreparationsIBA 11/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Olanzapine (Zyprexa)FDA Link 01/2017
1	LithiumIBA 01/2017
1	Dopamine D3 ReceptorsIBA 10/2016
1	LigandsIBA 10/2016

Therapy/Procedure

3	Secondary Prevention 01/2019 - 10/2016
3	Therapeutics 01/2019 - 03/2016
1	Drug Therapy (Chemotherapy) 01/2017